Sekeres, Mikkael A.
Swern, Arlene S.
Giagounidis, Aristoteles
List, Alan F.
Selleslag, Dominik
Mittelman, Moshe
Schlegelberger, Brigitte
Göhring, Gudrun
Li, Jack Shiansong
Sugrue, Mary M.
Fenaux, Pierre
Article History
Received: 9 February 2018
Accepted: 17 August 2018
First Online: 21 September 2018
Conflict of interest
: Dr. Sekeres has received research funding from Celgene Corporation. Dr. Swern and Dr. Li are employees of and hold equity in Celgene Corporation. Dr. Giagounidis is a consultant for and has received honoraria from Celgene Corporation. Dr. List is a consultant for and has received honoraria and research funding from Celgene Corporation. Dr. Selleslag is a consultant for and has received honoraria and research funding from Celgene Corporation, Novartis, Amgen, and GSK. Dr. Mittelman is a consultant for and has received honoraria and research funding from Celgene Corporation. Dr. Schlegelberger and Dr. Göhring have no conflicts of interest to disclose. Dr. Sugrue is a former employee of and holds equity in Celgene Corporation. Dr. Fenaux has received honoraria and research funding from Celgene Corporation.